Expression of Fcγ and complement receptors in monocytes of X-linked agammaglobulinaemia and common variable immunodeficiency patients

Clinical and Experimental Immunology

Volumn 150, Issue 3, 2007, Pages 422-428

  Amoras, A L B ^a   Da Silva, M T N ^a   Zollner, R L ^a   Kanegane, H ^b   Miyawaki, T ^b   Vilela, M M S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

CD18) receptors; Common variable immunodeficiency; CR1 (CD35); CR3 (CD11b; Fc ; Flow cytometry; Monocytes; X linked agammaglobulinaemia

Indexed keywords

BRUTON TYROSINE KINASE; CD11B ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR; FC RECEPTOR;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHEMOTAXIS; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DENSITY; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOPHENOTYPING; MALE; MONOCYTES; RECEPTORS, COMPLEMENT; RECEPTORS, IGG;

EID: 36048966875     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03512.x     Document Type: Article

References (35)

1. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993 72 : 279 90.
2. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 1993 361 : 226 33.
3. Futatani T, Miyawaki T, Tsukada S et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998 91 : 595 602.
4. Smith CI, Baskin B, Humire-Greiff P et al. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, Btk, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 1994 152 : 557 65.
5. Genevier HC, Hinshelwood S, Gaspar HB et al. Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur J Immunol 1994 24 : 3100 5.
6. Quek LS, Bolen J, Watson SP. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol 1998 8 : 1137 40.
7. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001 114 : 141 9.
8. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 2002 16 : 61 4.
9. Kanegane H, Taneichi H, Nomura K, Futatani T, Miyawaki T. Severe neutropenia in Japanese patients with X-linked agammaglobulinemia. J Clin Immunol 2005 25 : 490 5.
10. Brunner C, Müller B, Wirth T. Bruton's tyrosine kinase is involved in innate and adaptive immunity. Histol Histopathol 2005 20 : 945 55.
11. Mangla A, Khare A, Vineeth V et al. Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood 2004 104 : 1191 7.
12. Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000 120 : 225 31.
13. Chapel H, Geba R, Rosen F, IUIS PID (Primary Immunodeficiency) Classification Committee. Primary immunodeficiency diseases: an update. Clin Exp Immunol 2003 132 : 9 15.
14. Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 2005 11 : 370 6.
15. Amoras AL, Kanegane H, Miyawaki T, Vilela MM. Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. J Invest Allergol Clin Immunol 2003 13 : 181 8.
16. Aderen A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999 17 : 593 623.
17. Heijnen IAFM, van de Winkel JGJ. Human IgG Fc receptors. Int Rev Immunol 1997 16 : 29 55.
18. Lindvall JM, Blomberg KE, Valiaho J et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev 2005 203 : 200 15.
19. WHO Scientific Group. Primary immunodeficiency diseases. Clin Exp Immunol 1999 118 (Suppl. 1 1 28.
20. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006 211 : 609 18.
21. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001 69 : 11 20.
22. Gordon S, Taylor P. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005 5 : 953 64.
23. Gagliardi MC, Finocchi A, Orlandi P et al. Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function. Clin Exp Immunol 2003 133 : 115 22.
24. Hackam DJ, Rotstein OD, Schreiber A, Zhang WJ, Grinstein S. Rho is required for the initiation of calcium signaling and phagocytosis by Fc gamma receptors in macrophages. J Exp Med 1997 186 : 955 66.
25. Suzuki T, Kono H, Hirose N, Okada M, Yamamoto K, Honda Z. Differential involvement of Src family kinase in Fc gamma receptor-mediated phagocytosis. J Immunol 2000 165 : 473 82.
26. Nore BF, Vargas L, Mohamed AJ et al. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases. Eur J Immunol 2000 30 : 145 54.
27. Inabe K, Ishiai M, Scharenberg AM, Freshney N, Downward J, Kurosaki T. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J Exp Med 2002 195 : 189 200.
28. Fluckiger AC, Li ZM, Kato RM et al. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J 1998 17 : 1973 85.
29. Verma J, Arora V, Marwaha V, Kumar A, Das N. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus. Lupus 2005 14 : 273 9.
30. Thon V, Eggenbauer H, Wolf HM et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997 108 : 1 8.
31. Fischer MB, Hauber I, Wolf HM, Vogel E, Mannhalter JW, Eibl MM. Impaired TCR signal transduction, but normal antigen presentation, in a patient with common variable immunodeficiency. Br J Haematol 1994 88 : 520 6.
32. Viallard JF, Camou F, Andre M et al. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther 2005 7 : 1052 5.
33. Cambronero R, Sewell WA, North ME, Webster AD, Farrant J. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol 2000 164 : 488 94.
34. Braig DU, Schäffer AA, Glocker E et al. Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity. Hum Genet 2003 112 : 369 78.
35. Gollob JA, Li J, Kawasaki H et al. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 1996 157 : 1886 93.